Affordable Access

Publisher Website

Development of Korean Rome III Questionnaire: What Will We Do With Korean Rome III Questionnaire?

Authors
Journal
Journal of Neurogastroenterology and Motility
2093-0879
Publisher
The Korean Society of Neurogastroenterology and Motility (KAMJE)
Publication Date
Volume
19
Issue
4
Identifiers
DOI: 10.5056/jnm.2013.19.4.424
Keywords
  • Editorial
Disciplines
  • Medicine
  • Religious Science

Abstract

untitled JNM Journal of Neurogastroenterology and Motility Editorial 424 ⓒ 2013 The Korean Society of Neurogastroenterology and Motility J Neurogastroenterol Motil, Vol. 19 No. 4 October, 2013 www.jnmjournal.org J Neurogastroenterol Motil, Vol. 19 No. 4 October, 2013 pISSN: 2093-0879 eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm.2013.19.4.424 Development of Korean Rome III Questionnaire: What Will We Do With Korean Rome III Questionnaire? Yu Kyung Cho Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea Received: September 12, 2013 Revised: September 25, 2013 Accepted: September 25, 2013 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. *Correspondence: Yu Kyung Cho, MD Department of Internal Medicine, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul St. Mary’s Hospital, Seoul 137-049, Korea Tel: +82-2-2258-6024, Fax: +82-2-2258-2055, E-mail: [email protected] Financial support: None. Conflicts of interest: None. Article: Development and validation of the Korean Rome III questonnaire for diagnosis of functional gastrointestinal disorders Song KH, Jung HK, Min BH, et al. (J Neurogastroenterol Motil 2013;19:509-515) Functional gastrointestinal disorders (FGIDs) are common in clinical practice and in communities around the world, includ- ing Korea. In 2006, definitions and classifications of FGIDs were revised in Rome III. The major points of the Rome III in- clude: (1) changes in the time frame for diagnosis of FGIDs from 12 months to 6 months for the onset, and from 6 months to 3 months for the activity of the symptoms; (2) changes in func- tional dyspepsia (FD) to postprandial distress and epigastric pain syndromes (PDS and EPS), focusing o

There are no comments yet on this publication. Be the first to share your thoughts.